Vivos Therapeutics Schedules Release of Third Quarter 2023 Financial Results and Conference Call
Vivos Therapeutics, Inc. (“Vivos” or the “company”) (NASDAQ: VVOS), a medical technology company focused on developing innovative treatments for patients suffering from dentofacial.